# Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals ("SHAC Neuro Study")

> **NCT01985399** · — · COMPLETED · sponsor: **Stanford University** · enrollment: 100 (actual)

## Conditions studied

- HIV
- AIDS

## Interventions

- **BEHAVIORAL:** Neuropsychological testing

## Key facts

- **NCT ID:** NCT01985399
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01985399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01985399, "Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals ("SHAC Neuro Study")". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01985399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*